Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.pnpbp.2020.110207 http://scihub22266oqcxt.onion/10.1016/j.pnpbp.2020.110207 33338558!7834650!33338558     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Prog+Neuropsychopharmacol+Biol+Psychiatry 2021 ; 109 (ä): 110207 Nephropedia Template TP {{tp|p=33338558|t=2021. Prevalence of anxiety in the COVID-19 pandemic: An updated meta-analysis of community-based studies |pdf=|usr=}}{{33338558}} gab.com Text Prevalence of anxiety in the COVID-19 pandemic: An updated meta-analysis of community-based studies JO: Prog Neuropsychopharmacol Biol Psychiatry http://www.kidney.de/pget.php?&tw=1&pmid=33338558 #FOAvip BACKGROUND: The unprecedented worldwide crisis caused by the rapid spread of COVID-19 and the restrictive public health measures enforced by some countries to slow down its transmission have severely threatened the physical and mental wellbeing of communities globally. METHODS: We conducted a systematic review and meta-analysis to determine the prevalence of anxiety in the general population during the COVID-19 pandemic. Two researchers independently searched for cross-sectional community-based studies published between December 1, 2019 and August 23, 2020, using PubMed, WoS, Embase, and other sources (e.g., grey literature, manual search). RESULTS: Of 3049 records retrieved, 43 studies were included. These studies yielded an estimated overall prevalence of anxiety of 25%, which varied significantly across the different tools used to measure anxiety. Consistently reported risk factors for the development of anxiety included initial or peak phase of the outbreak, female sex, younger age, marriage, social isolation, unemployment and student status, financial hardship, low educational level, insufficient knowledge of COVID-19, epidemiological or clinical risk of disease and some lifestyle and personality variables. CONCLUSIONS: As the overall global prevalence of anxiety disorders is estimated to be 7.3% normally, our results suggest that rates of anxiety in the general population could be more than 3 times higher during the COVID-19 pandemic. These findings suggest a substantial impact on mental health that should be targeted by individual and population-level strategies. Twit Text FOAVip Prevalence of anxiety in the COVID-19 pandemic: An updated meta-analysis of community-based studies ????Prog Neuropsychopharmacol Biol Psychiatry http://www.kidney.de/pget.php?&tw=1&pmid=33338558 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33338558 #FOAvip English Wikipedia <ref>{{Cite pmid|33338558}}</ref> Prevalence of anxiety in the COVID-19 pandemic: An updated meta-analysis of community-based studies #MMPMID33338558 Santabarbara J; Lasheras I; Lipnicki DM; Bueno-Notivol J; Perez-Moreno M; Lopez-Anton R; De la Camara C; Lobo A; Gracia-Garcia P Prog Neuropsychopharmacol Biol Psychiatry 2021[Jul]; 109 (ä): 110207 PMID33338558show ga BACKGROUND: The unprecedented worldwide crisis caused by the rapid spread of COVID-19 and the restrictive public health measures enforced by some countries to slow down its transmission have severely threatened the physical and mental wellbeing of communities globally. METHODS: We conducted a systematic review and meta-analysis to determine the prevalence of anxiety in the general population during the COVID-19 pandemic. Two researchers independently searched for cross-sectional community-based studies published between December 1, 2019 and August 23, 2020, using PubMed, WoS, Embase, and other sources (e.g., grey literature, manual search). RESULTS: Of 3049 records retrieved, 43 studies were included. These studies yielded an estimated overall prevalence of anxiety of 25%, which varied significantly across the different tools used to measure anxiety. Consistently reported risk factors for the development of anxiety included initial or peak phase of the outbreak, female sex, younger age, marriage, social isolation, unemployment and student status, financial hardship, low educational level, insufficient knowledge of COVID-19, epidemiological or clinical risk of disease and some lifestyle and personality variables. CONCLUSIONS: As the overall global prevalence of anxiety disorders is estimated to be 7.3% normally, our results suggest that rates of anxiety in the general population could be more than 3 times higher during the COVID-19 pandemic. These findings suggest a substantial impact on mental health that should be targeted by individual and population-level strategies. |*Pandemics[MESH] |Adult[MESH] |Anxiety/*epidemiology/*etiology/psychology[MESH] |COVID-19/*psychology[MESH] |Female[MESH] |Humans[MESH] |Male[MESH]Prevalence of anxiety in the COVID-19 pandemic: An updated meta-analys(epmc).pdf DeepDyve Pubget Overpricing